-
Mashup Score: 0Logon - Scholarship Lifecycle Manager - 7 month(s) ago
The commonly seen suffixes for KB and MB do not always mean the same thing on different computers. KB can m ean 1000 bytes or 1024 bytes and MB can mean 1000 KB or 1024 KB depending on the computer you are using. On one computer, 1 MB might mean 1,000,000 bytes, and on another computer 1 MB might mean 1,048,576 bytes (1024×1024). Because of this difference, a file on one computer that reports being 1 MB can be a different size than a file that shows 1 MB on another computer. We display sizes in MiB for
Source: www.grantinterface.comCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 0Exercise Rehabilitation Found to Help Alleviate Symptoms of Several Chronic Respiratory Diseases - 10 month(s) ago
Researchers discovered that exercise helps to alleviate various symptoms for patients with chronic obstructive pulmonary disease, bronchial asthma, bronchiectasis, interstitial lung disease, and lung cancer.
Source: AJMCCategories: Latest Headlines, PayerTweet-
Researchers discovered that exercise helps to alleviate various symptoms for patients with #ChronicObstructivePulmonaryDisease, #BronchialAsthma, #Bronchiectasis, #InterstitialLungDisease, and #LungCancer. https://t.co/CKK2PC2NUl https://t.co/Bur3VIxoef
-
-
Mashup Score: 2Interstitial Lung Disease in Veterans: Leveraging Big Data to Bridge the Evidence and Practice Gaps - 1 year(s) ago
U.S. government reform provides impetus to healthcare and extends benefits to veteran patients with interstitial lung disease (ILD). An article published in …
Source: YouTubeCategories: Latest Headlines, PulmonologyTweet-
This @AnnalsATS study shows how the #PACT Act passed by the U.S. government is providing impetus to #healthcare and extending benefits to #veteran patients with #interstitiallungdisease. Learn more here: https://t.co/6XrzqtNgSA
-
-
Mashup Score: 0Source: link.springer.comCategories: Latest Headlines, RheumatologyTweet
-
A multidisciplinary approach to the assessment of patients with #SystemicSclerosis-associated #InterstitialLungDisease #SSc #ILD 👉https://t.co/uJ1cQzN69O https://t.co/LXHgBrUVDr
-
-
Mashup Score: 9
Objective Interstitial lung disease (ILD) is a common extramuscular complication contributing to significant morbidity and mortality in patients with dermatomyositis (DM) who are positive for antimelanoma differentiation–associated gene 5 antibody (anti-MDA5+). We conducted this study to investigate the association of anti-Ro52 antibodies with clinical characteristics and prognosis in patients…
Source: The Journal of RheumatologyCategories: Latest Headlines, RheumatologyTweet-
Research Article Coexistence of Anti-Ro52 Antibodies in Anti-MDA5 Antibody–Positive Dermatomyositis Is Highly Associated With Rapidly Progressive Interstitial Lung Disease and Mortality Risk 📰 https://t.co/YTmz1Nlkzf #dermatomyositis #interstitiallungdisease #mortalityrisk https://t.co/1Hiryt4SMR
-
-
Mashup Score: 0
Objective The efficacy of tofacitinib (TOF) in the early diagnosis of melanoma differentiation–associated gene 5 (MDA5)–related interstitial lung disease (ILD) has been described. However, whether TOF exposure is associated with a reduced 1-year mortality rate remains undetermined. Methods Patients diagnosed with MDA5-ILD receiving TOF or tacrolimus (TAC) treatment were included. A Cox…
Source: The Journal of RheumatologyCategories: Latest Headlines, RheumatologyTweet-
A Retrospective Analysis of Outcome in Melanoma Differentiation–Associated Gene 5–Related Interstitial Lung Disease Treated with Tofacitinib or Tacrolimus 📰 https://t.co/I9yqcSg9ua #interstitiallungdisease #tofacitinib #tacrolimus https://t.co/SSKBrzmEV2
-
-
Mashup Score: 0Assessment of disease outcome measures in systemic sclerosis - Nature Reviews Rheumatology - 2 year(s) ago
Assessing systemic sclerosis (SSc) disease activity is challenging, and improved outcome measures are needed. This Review describes clinical and biochemical outcome measures of distinct features of SSc, with an emphasis on the dermatological manifestations and interstitial lung disease, including insights into biomarkers gained from single-cell RNA sequencing.
Source: NatureCategories: Latest Headlines, RheumatologyTweet-
#SeptemberIssue | In this #Review, Robert Lafyatis & @EleanorValenzi (@PACCM) describe #SystemicSclerosis outcome measures, with emphasis on #dermatological manifestations and #InterstitialLungDisease https://t.co/iH9vL9yFN8 https://t.co/MYAk4gZjC6
-
-
Mashup Score: 0
The risk of ILD/pneumonitis was associated with patient age, time since cancer diagnosis, dose of trastuzumab deruxtecan, and other factors.
Source: Cancer Therapy AdvisorCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#TrastuzumabDeruxtecan may lead to #interstitialLungDisease /pneumonitis in a subset of patients with cancer, according to research published in @ESMO_Open with @IcahnMountSinai. https://t.co/QEZHKE73sW #ILD
-
-
Mashup Score: 0T-DXd Interstitial Lung Disease: Controllable Adverse Eve... - 2 year(s) ago
Is Interstitial Lung Disease a Manageable Adverse Event of Trastuzumab T-DXd Deruxtecan Treatment? What is Trastuzumab T-DXd? Trastuzumab T-DXd is an antibody-drug conjugate that consists of an antibody that binds to the HER-2 receptor that can be over-expressed or mutated in several different cancers. That is covalently linked to a payload. In this case, it’s a topoisomerase one inhibitor, a…
Source: oncologytube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🤔 T-DXd & Interstitial Lung Disease: Controllable Adverse Event? 📊 https://t.co/G4hQv9ww1N @CAP_MDNY @IcahnMountSinai #trastuzumab #InterstitialLungDisease #T-DXd https://t.co/l55Hh5XJiI
-
-
Mashup Score: 0
The data obtained from the study supported the idea that IL-6 could be used as a potential marker for judging the efficacy of SSc.
Source: HCPLive®Categories: General Medicine News, Latest HeadlinesTweet-
New data from indicated that cytokine IL-6 in the serum of patients with #systemicsclerosis was associated with #interstitiallungdisease, #pulmonaryarterialhypertension (PAH), gastrointestinal involvement and cardiac involvement. https://t.co/UAgJ3sg9PS https://t.co/UAgJ3sg9PS
-
We're accepting applications for the ATS Research Award in #InterstitialLungDisease (ILD)!📝 The focus of this grant is research in the area of ILD. This award is supported by an independent grant from @Boehringer. 📆 Deadline: Jan. 8 🔗 Apply: https://t.co/8YMaKo8Ys1 https://t.co/pt7UQCmVfm